GB987009A - Improvements in or relating to antibiotic compositions and the preparation thereof - Google Patents
Improvements in or relating to antibiotic compositions and the preparation thereofInfo
- Publication number
- GB987009A GB987009A GB38832/63A GB3883263A GB987009A GB 987009 A GB987009 A GB 987009A GB 38832/63 A GB38832/63 A GB 38832/63A GB 3883263 A GB3883263 A GB 3883263A GB 987009 A GB987009 A GB 987009A
- Authority
- GB
- United Kingdom
- Prior art keywords
- novobiocin
- pellets
- tetracycline
- relating
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Solid dosages of oral medicaments comprise a tetracycline antibiotic and novobiocin, the latter being contained in from 5 to 2000 "pellets," i.e. discrete particles, e.g. granules, pilules, spheres or compressed powders having sufficient integrity to withstand formulation into a single dosage unit such as a hard or soft gelatine capsule or a tablet. Optionally, the pellets may be coated with a material which will delay the release of novobiocin in the stomach for about 10 to 20 minutes, e.g. styrene-maleic acid copolymer, ethyl cellulose or a fatty or waxy material and they may contain an anionic or non-ionic surfactant. Specified tetracyclines include the bases tetracycline, chlortetracycline, oxytetracycline and demethyltetracycline and their pharmaceutically acceptable acid addition salts. The novobiocin may be in any form other than the crystalline free acid.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US238051A US3220925A (en) | 1962-11-15 | 1962-11-15 | Tetracycline-novobiocin compositions and method of use |
Publications (1)
Publication Number | Publication Date |
---|---|
GB987009A true GB987009A (en) | 1965-03-24 |
Family
ID=22896297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB38832/63A Expired GB987009A (en) | 1962-11-15 | 1963-10-02 | Improvements in or relating to antibiotic compositions and the preparation thereof |
Country Status (2)
Country | Link |
---|---|
US (1) | US3220925A (en) |
GB (1) | GB987009A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5328697A (en) * | 1992-02-10 | 1994-07-12 | Mallinckrodt Veterinary, Inc. | Compositions and processes for the sustained release of drugs |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3070501A (en) * | 1957-02-21 | 1962-12-25 | Merck & Co Inc | Suppression of amorphous novobiocin crystallization in aqueous suspensions |
US2954323A (en) * | 1958-10-06 | 1960-09-27 | Abbott Lab | Thin film coating for tablets and the like |
US2928770A (en) * | 1958-11-28 | 1960-03-15 | Frank M Bardani | Sustained action pill |
US2994639A (en) * | 1958-12-16 | 1961-08-01 | Upjohn Co | Antibiotic composition |
-
1962
- 1962-11-15 US US238051A patent/US3220925A/en not_active Expired - Lifetime
-
1963
- 1963-10-02 GB GB38832/63A patent/GB987009A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
US3220925A (en) | 1965-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3344029A (en) | Sustained release composition | |
US3773920A (en) | Sustained release medicinal composition | |
US3427378A (en) | Sustained release encapsulated formula | |
ES403435A1 (en) | Slow release pharmaceutical compositions | |
US5532274A (en) | Orally administerable drugs for the treatment of central dopamine deficiency conditions | |
GR3017737T3 (en) | Low dose dry pharmaceutical preparations. | |
ES423856A1 (en) | Delayed release pharmaceutical preparations | |
GB1116438A (en) | Sustained relief analgesic composition | |
GB885081A (en) | Improvements in or relating to therapeutic compositions containing (acetylsalicylic acid)-anhydride | |
KR930701963A (en) | Solvent-free oral pharmaceutical composition with delayed release of active ingredient and method for preparing the composition | |
GB1283054A (en) | Improvements in and relating to delayed release veterinary and pharmaceutical compositions | |
GB934089A (en) | Improvements in or relating to sustained release medicaments | |
ES370058A1 (en) | Antibiotic compositions | |
GB987009A (en) | Improvements in or relating to antibiotic compositions and the preparation thereof | |
GB1209093A (en) | Pharmaceutical preparation | |
ES297425A1 (en) | Procedure for preparing pharmaceutical compositions in the form of deferred action tablets (Machine-translation by Google Translate, not legally binding) | |
GB630439A (en) | Improvements in or relating to pharmaceutical preparations | |
FR2108032A1 (en) | Prolonged progressively released oral medicament - comprises a solid excipient and cellulose dicarboxylic acid binder | |
US2864744A (en) | Penicillin in solid dosage unit form | |
US3660574A (en) | Method of controlling fertility employing quingestanol acetate | |
GB1108299A (en) | Sustained release dosage forms and their preparation | |
GB904378A (en) | Pharmaceutical compositions for oral administration comprising 6 alpha fluoroprednisolone and 21 esters thereof | |
GB1064582A (en) | Lipid-containing sustained release pharmaceutical compositions | |
ES273779A3 (en) | A method of doing pharmaceutical preparations administrables by oral (Machine-translation by Google Translate, not legally binding) | |
GB993601A (en) | Antiviral compositions comprising adenine derivatives |